Oncology Health Outcomes Strategist

Eli Lilly and Company seeks an Health Outcomes Liaison to serve as the HEOR interface with US population-based decision makers, supporting formulary access and patient outcomes through evidence and collaboration. The role emphasizes clinical evidence, RWE, and pharmacoeconomics in a field-based US setting. The HOL collaborates cross-functionally, translating complex data into actionable insights while aligning with internal teams to accelerate equitable patient access and improve health outcomes